Structural and molecular basis for Ebola virus neutralization by protective human antibodies.
Misasi, J., Gilman, M.S., Kanekiyo, M., Gui, M., Cagigi, A., Mulangu, S., Corti, D., Ledgerwood, J.E., Lanzavecchia, A., Cunningham, J., Muyembe-Tamfun, J.J., Baxa, U., Graham, B.S., Xiang, Y., Sullivan, N.J., McLellan, J.S.(2016) Science 351: 1343-1346
- PubMed: 26917592 
- DOI: 10.1126/science.aad6117
- Primary Citation of Related Structures:  
- PubMed Abstract: 
Ebola virus causes hemorrhagic fever with a high case fatality rate for which there is no approved therapy. Two human monoclonal antibodies, mAb100 and mAb114, in combination, protect nonhuman primates against all signs of Ebola virus disease, includ ...